Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04372251

Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach

Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach - A Randomized Controlled Multicenter Trial

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Ostfold Hospital Trust · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

In this randomized controlled trial, the outcomes of two surgical techniques for intraarticular calcaneal fractures will be evaluated and compared.

Detailed description

Operative treatment of calcaneal features through an extensile lateral approach (ELA) has been the gold standard over many years despite high rates of infection and soft tissue complications. Lately, there has been a trend towards less invasive fixation methods. Minimally invasive plate osteosynthesis using the sinus tarsi approach (STA) has gained popularity during the last decade. Furthermore, percutaneous reduction and fixation techniques have been described and used for a few decades. In the early 2000s, Rammelt et al. were the first who introduced a percutaneous technique assisted by hindfoot arthroscopy. The percutaneous and arthroscopically assisted calcaneal osteosynthesis (PACO) is applicable in Sanders II and III fractures and has been shown to provide good clinical outcomes as well as a low rate of complications. The study is designed as a superiority study. Our hypothesis is that the percutaneous and arthroscopically assisted technique provides superior outcomes compared to the sinus tarsi approach in Sanders II and III calcaneal fractures.

Conditions

Interventions

TypeNameDescription
PROCEDURESinus tarsi approach (STA)Osteosynthesis
PROCEDUREPercutaneous Arthroscopically Assisted Osteosynthesis (PACO)Osteosynthesis

Timeline

Start date
2020-05-05
Primary completion
2030-12-01
Completion
2031-12-01
First posted
2020-05-04
Last updated
2024-12-09

Locations

5 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT04372251. Inclusion in this directory is not an endorsement.